Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT03034200
What this trial is testing

Phase 2 Study of ONC201 in Neuroendocrine Tumors

Who this might be right for
Recurrent Neuroendocrine TumorMetastatic Neuroendocrine Tumor
Peter Anderson 30
Not applicableLooking for participantsNCT07570407
What this trial is testing

Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic HSCTPosttransplant ComplicationsGvHD+2 more
University Hospital Pilsen 75
Testing effectiveness (Phase 2)Study completedNCT02301611
What this trial is testing

Phase IIB TL + YCWP + DC in Melanoma

Who this might be right for
Melanoma
Elios Therapeutics, LLC 187
Testing effectiveness (Phase 2)Study completedNCT00004211
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Duke University 17
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00964171
What this trial is testing

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Bergonié 19
Early research (Phase 1)Not Yet RecruitingNCT06500507
What this trial is testing

QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Qilu Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT00003367
What this trial is testing

Diet and PSA Levels in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 154
Early research (Phase 1)Study completedNCT02009436
What this trial is testing

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 8
Early research (Phase 1)Ended earlyNCT01744171
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT02792036
What this trial is testing

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

Who this might be right for
Retinoblastoma
St. Jude Children's Research Hospital 8
Early research (Phase 1)UnknownNCT05883007
What this trial is testing

Dose Optimized BNCT for Head and Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma
Southern Tohoku BNCT Research Center 30
Large-scale testing (Phase 3)WithdrawnNCT03048136
What this trial is testing

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT02271711
What this trial is testing

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
M.D. Anderson Cancer Center 12
Early research (Phase 1)Ended earlyNCT03103971
What this trial is testing

HuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma+14 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07644208
What this trial is testing

PD-1/IL-2 Bispecific Antibody as Neoadjuvant Therapy for Early Recurrent Hepatocellular Carcinoma After Curative Hepatectomy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital 30
Not applicableStudy completedNCT05300789
What this trial is testing

Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients

Who this might be right for
Peritoneal CarcinomatosisColon Cancer
Carlos Cerdán Santacruz 1,152
Early research (Phase 1)Active Not RecruitingNCT02474368
What this trial is testing

Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck

Who this might be right for
Recurrent Head and Neck CarcinomaHead and Neck Cancer MetastaticHead or Neck Cancer
Dana-Farber Cancer Institute 21
Next Page